# Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Source: https://onco.cc/trials/nct03678025/  
OnCo record `nct03678025` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Abiraterone acetate, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin / leuprolide, Histrelin, Leuprolide, Nilutamide, Prednisone and Triptorelin in Prostate cancer, run by SWOG Cancer Research Network, now recruiting.

## Summary

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer is a phase 3 interventional study registered as NCT03678025 by SWOG Cancer Research Network, with 1273 participants planned, started 2018-09-24 and due to reach its primary completion in 2028-04-01. Interventions recorded: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin Acetate, Histrelin Acetate, Leuprolide Acetate, Nilutamide, Orchiectomy, Prednisone, Quality-of-Life Assessment, Radiation Therapy, Radical Prostatectomy, Triptorelin. Conditions recorded: Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8.

Linked to the drug Flutamide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03678025
- Phase: 3
- Setting: Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
- Sponsor: SWOG Cancer Research Network
- Enrolled: 1273

## Sources

- ClinicalTrials.gov NCT03678025: https://clinicaltrials.gov/study/NCT03678025

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Abiraterone acetate](https://onco.cc/drugs/abiraterone/), [Bicalutamide](https://onco.cc/drugs/bicalutamide/), [Degarelix](https://onco.cc/drugs/degarelix/), [Docetaxel](https://onco.cc/drugs/docetaxel/), [Flutamide](https://onco.cc/drugs/flutamide/), [Goserelin / leuprolide (ovarian function suppression)](https://onco.cc/drugs/goserelin/), [Histrelin](https://onco.cc/drugs/histrelin/), [Leuprolide (leuprorelin) and GnRH agonists](https://onco.cc/drugs/leuprolide/), [Nilutamide](https://onco.cc/drugs/nilutamide/), [Prednisone](https://onco.cc/drugs/prednisone/), [Triptorelin](https://onco.cc/drugs/triptorelin/)

---
JSON: https://onco.cc/api/v1/entities/nct03678025.json